Adalimumab
Showing 801 - 818 of 818
Crohn's Disease Trial in United States (adalimumab)
Completed
- Crohn's Disease
- adalimumab
-
Birmingham, Alabama
- +96 more
Nov 28, 2007
Rheumatoid Arthritis Trial in Abbott Park (adalimumab, methotrexate)
Completed
- Rheumatoid Arthritis
- adalimumab
- methotrexate
-
Abbott Park, IllinoisGlobal Medical Information - Abbott
Aug 28, 2007
Psoriatic Arthritis Trial in Abbott Park (Human anti-TNF mAb/adalimumab)
Completed
- Psoriatic Arthritis
- Human anti-TNF monoclonal antibody/adalimumab
-
Abbott Park, IllinoisGlobal Medical Information-Abbott Laboratories
Aug 28, 2007
Focal Glomerulosclerosis Trial in New Hyde Park, Chapel Hill (Rosiglitazone (Avandia), Adalimumab (Humira))
Completed
- Focal Glomerulosclerosis
- Rosiglitazone (Avandia)
- Adalimumab (Humira)
-
New Hyde Park, New York
- +1 more
Oct 19, 2007
Rheumatoid Arthritis Trial in North Chicago (adalimumab)
Completed
- Rheumatoid Arthritis
- adalimumab
-
North Chicago, IllinoisGlobal Medical Information - Abbott
Aug 28, 2007
Crohn's Disease Trial in United States (Adalimumab)
Completed
- Crohn's Disease
- Adalimumab
-
La Jolla, California
- +42 more
Sep 23, 2007
Ankylosing Spondylitis Trial in Worldwide (adalimumab (Humira))
Completed
- Ankylosing Spondylitis
- adalimumab (Humira)
-
Graz, Austria
- +204 more
Oct 4, 2007
Rheumatoid Arthritis Trial in Canada, United States (tgAAC94 gene therapy vector, tgAAC94 )
Completed
- Rheumatoid Arthritis
- tgAAC94 gene therapy vector
- tgAAC94 placebo
-
Los Angeles, California
- +6 more
Feb 5, 2008
Rheumatoid Arthritis Trial in North Chicago (adalimumab (up to 9 months exposure), methotrexate)
Terminated
- Rheumatoid Arthritis
- adalimumab (up to 9 months exposure)
- methotrexate
-
North Chicago, IllinoisGlobal Medical Information - Abbott
Apr 23, 2007
Crohn's Disease Trial in United States (Adalimumab (D2E7))
Completed
- Crohn's Disease
- Adalimumab (D2E7)
-
Berkeley, California
- +42 more
Aug 11, 2006
Crohn's Disease Trial in Worldwide (Adalimumab)
Completed
- Crohn's Disease
- Adalimumab
-
Huntsville, Alabama
- +55 more
Aug 13, 2006
Osteoarthritis Trial in Stanford (Adalimumab)
Completed
- Osteoarthritis
- Adalimumab
-
Stanford, CaliforniaStanford University
Mar 23, 2006
Rheumatoid Arthritis, Arthritis Trial in Paris (Adalimumab, Methotrexate)
Unknown status
- Rheumatoid Arthritis
- Arthritis
- Adalimumab
- Methotrexate
-
Paris, FranceHopital Cochin
Feb 14, 2006
Rheumatoid Arthritis Trial in United States (Adalimumab)
Completed
- Rheumatoid Arthritis
- Adalimumab
-
Mobile, Alabama
- +53 more
Aug 13, 2006
Ankylosing Spondylitis Trial in Berlin, Herne (Adalimumab 40 mg sc every other week)
Unknown status
- Ankylosing Spondylitis
- Adalimumab 40 mg sc every other week
-
Berlin, Germany
- +1 more
Dec 8, 2005
Infections and Lymphoma in Patients Treated With TNF-a
Unknown status
- Rheumatoid Arthritis
- +3 more
- TNF-alpha antagonists
-
All Cities, FranceAll French departments of rheumatology, internal medicine, gastr
Oct 25, 2005